ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Friday, 26 January

08.30 - 08.40 Welcome Location: Plenary Room M. Brausi, Modena (IT)

08.40 - 09.00 Opening address The future of urology: The EAU perspective F. Debruyne, Arnhem (NL)

09.00 - 13.10 Prostate Cancer I: Diagnosis, pathology, screening, active surveillance Chairs: M. Brausi, Modena (IT) F. Debruyne, Arnhem (NL)

09.00 - 09.15 Reflex testing with serum, urine and tissue biomarkers: Which, when and how viable? B. Djavan, Vienna (AT)

09.15 - 09.20 Questions

09.20 - 09.35 Genetic testing in inherited prostate cancer A. Alcaraz, Barcelona (ES)

09.35 - 09.40 Questions

09.40 - 09.55 Morphologic basis of mpMRI prostate cancer evaluation F. Algaba, Barcelona (ES)

09.55 - 11.30 MRI imaging targeted prostate biopsy: Comparing 3 different techniques. Is there really a difference in results?

09.55 - 10.05 Fusion biopsy R. Sanchez Salas, Paris (FR)

10.05 - 10.15 In-bore biopsy M. Sedelaar, Nijmegen (NL)

10.15 - 10.25 Cognitive biopsy O. Rouviere, Lyon (FR)

10.25 - 10.45 Discussion with clinical cases J. Barentsz, Nijmegen (NL)

10.45 - 11.00 MRI in men on active surveillance for prostate cancer: The PRECISE recommendations C. Moore, London (GB)

11.00 - 11.15 Biopsy or monitoring patients with negative MRI J. Hugosson, Gothenburg (SE)

11.15 - 11.30 Discussion

11.30 - 12.00 Break

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Friday, 26 January

12.00 - 12.15 How have recommendations against prostate cancer screening impacted the incidence and mortality of prostate cancer in the US

C. Evans, Sacramento (US)

12.15 - 12.25 Discussion

12.25 - 13.10 ROUND TABLE: Treatment modalities for intermediate risk prostate cancer: surgery vs hypofractionation RT vs focal therapy vs active surveillance

Chairs: J. Hugosson, Gothenburg (SE) A. Villers, Lille (FR) 12.25 - 12.33 Surgery S. Joniau, Leuven (BE)12.33 - 12.41 Hypofractionation RT C. Cozzarini, Milan (IT)12.41 - 12.49 Focal therapy A. Villers, Lille (FR)12.49 -12.57 Active surveillance M. Roobol, Rotterdam (NL)12.57 - 13.10 Discussion

13.10 - 14.00 Lunch

14.00 - 16.45 Renal cancer I: Localised: Alternative approaches for characterisation of renal tumours Chairs: P. Chlosta, Cracow (PL) A. Volpe, Novara (IT)

14.00 - 14.10 MRI J. Walz, Marseilles (FR)

14.10 - 14.20 Conventional and optical renal mass biopsy T. De Reijke, Amsterdam (NL)

14.20 - 14.30 Liquid biopsy M. von Brandenstein, Cologne (DE)

14.30 - 14.45 Discussion

14.45 - 15.00 The WHO ISUP classification of renal tumours: What has changed? G. Martignoni, Verona (IT)15.00 - 15.05 Discussion

15.05 - 15.30 Treatment of renal cancer in the elderly (>75years) Chairs: A. Minervini, Florence (IT) H. Van Poppel, Leuven (BE) 15.05 - 15.30 Is partial nephrectomy always the best choice for T1b tumours?15.05 - 15.15 Yes G. Janetschek, Salzburg (AT)15.15 - 15.25 No M. Kuczyk, Hanover (DE)15.25 - 15.30 Discussion

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Friday, 26 January

15.30 - 16.00 DEBATE: Clamped vs. unclamped partial nephrectomy (open, lap. robotic)

15.30 - 15-40 Clamped P. Chlosta, Cracow (PL)

15.40 - 15.50 Unclamped M. Gallucci, Rome (IT)

15.50 - 16.00 Discussion

16.00 - 16.30 Panel discussion of clinical cases: Localised RCC Chair: P. Mulders, Nijmegen (NL) Panelists: A. Breda, Barcelona (ES) G. Stewart, Cambridge (GB) H. Van Poppel, Leuven (BE) J. Walz, Marseilles (FR)

16.30 - 16.45 Surveillance after nephrectomy: On the way towards evidence based protocols A. Bex, Amsterdam (NL)

16.45 - 17.15 Break

17.15 - 18.50 Controversial subjects on bladder cancer The role of extended lymphadenectomy for bladder cancer Chairs: G. Thalmann, Berne (CH) E. Xylinas, Paris (FR)

17.15 - 17.25 The American perspective C. Evans, Sacramento (US)

17.25 - 17.35 European perspective R. Hautmann, Neu-Ulm (DE)

17.35 - 17.45 Discussion

17.45 -18.10 Robotic assisted radical cystectomy: Always the right urinary diversion?17-45 - 17.55 No G. Thalmann, Berne (CH)17.55 - 18.05 Yes H. Van Der Poel, Amsterdam (NL)18.05 - 18.10 Discussion

18.10 - 18.50 Is there a role for local treatment in metastatic disease?18.10 - 18.20 The urologist perspective A. Stenzl, Tubingen (DE)18.20 - 18.30 The medical oncologist perspective A. Necchi, Milan (IT)18.30 - 18.40 Discussion

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Saturday, 27 January

08.30 – 11.30 Prostate cancer II: Locally advanced Location: Plenary Room Chairs: A. Alcaraz, Barcelona (ES) S. Joniau, Leuven (BE)

08.30 – 08.45 Tools for detection of node metastasis: PSMA guided surgery T. Maurer, Munich (DE)

08.45 – 09.40 Management of loco-regional recurrence after definitive treatment

08.45 – 09.00 Cryoablation B. Malavaud, Toulouse (FR)

09.00 – 09.15 Salvage radiation therapy A. Bossi, Villejuif (FR)

09.15 - 09.30 Salvage radical prostatectomy – Robotic H. Van Der Poel, Amsterdam (NL)

09.30 - 09.40 Discussion

09.40 – 10.20 DEBATE: Reappraisal of neoadjuvant therapy for high and very high-risk PCA

09.40 – 09.55 Yes - it does make sense A. Volpe, Novara (IT)

09.55 - 10.10 No - it is useless N. Mottet, Saint Etienne (FR)

10.10 – 10.20 Discussion

10.20 – 11.00 Is lymph node dissection necessary in prostate cancer?

10.20 - 10.35 The American view C. Evans, Sacramento (US)

10.35 – 10.50 The European view M. Graefen, Hamburg (DE)

10.50 - 11.00 Discussion

11.00 - 11.30 Break

11.30 - 12.20 Penile cancer Reducing treatment aggressiveness without impairing outcomes Chairs: B. Ayres, London (GB) D. Pfister, Cologne (DE)

11.30 – 11.40 Conservative surgery for penile cancer: Indications and techniques S. Minhas, London (GB)

11.40 - 11.45 Discussion

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Saturday, 27 January

11.45 – 11.55 From radical inguinal lymph node dissection to sentinel lymph node dissection for penile cancer B. Ayres, London (GB)

11.55 – 12.00 Discussion

12.00 - 12.10 Evolution of surgical techniques in testis cancer D. Pfister, Cologne (DE)

12.10 - 12.20 Discussion

12.20 – 14.10 Urothelial cancer II: Non muscle invasive bladder cancer Chairs: J. Catto, Sheffield (GB) J. Palou, Barcelona (ES)

12.20 - 12.30 New techniques for bladder tumour resection: Are they better than conventional TURBT? U. Nagele, Hall (AT)

12.30 - 12.35 Discussion

12.35 – 12 45 Complications of TURBT A. Masson-Lecomte, Creteil (FR)

12.45 - 12.50 Discussion

12.50 - 13.00 Socio-economic impact of BCG shortage M. Colombel, Lyon (FR)

13.00 – 13.05 Discussion

13.05 - 13.15 Genomic classification of non muscle invasive bladder tumours J. Catto, Sheffield (GB)

13.15 – 13.20 Discussion

13.20 – 13.30 New diagnostic tools for upper urinary tract TCC A. Breda, Barcelona (ES)

13.30 – 13.35 Discussion

13.35 – 14.10 Panel discussion – Second opinion in difficult clinical cases Chair: M. Babjuk, Prague (CZ) Panelists: J. Catto, Sheffield (GB) M. Colombel, Lyon (FR) J. Palou, Barcelona (ES) E. Xylinas, Paris (FR)

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Sunday, 28 January

09.00 - 10.30 Prostate cancer III: Advanced and metastatic disease Location: Plenary Room Chairs: G. Janetschek, Salzburg (AT) H. Van Der Poel, Amsterdam (NL)

09.00 - 09.15 Open vs robotic surgery for locally advanced prostate cancer: Oncological and functional outcomes P. Gontero, Turin (IT)

09.15 - 09.20 Discussion

09.20 - 10.00 New trends for treatment of oligo metastatic prostate cancer

09.20 - 09.30 Radical prostatectomy M. Brausi, Modena (IT)

09.30 - 09.40 Radiotherapy B. Jereczek-Fossa, Milan (IT)

09.40 - 09.50 Chemo-hormone therapy N. Mottet, Saint Etienne (FR)

09.50 - 10.00 Discussion

10.00 - 10.30 Salvage LND after radical prostatectomy for PSA recurrence: An up-date

10.00 - 10.10 Robotic (Video) N. Suardi, Milan (IT)

10.10 - 10.20 Open (Video) S. Joniau, Leuven (BE)

10.20 - 10.30 Discussion

10.30 - 11.00 Break

11.00 - 12.00 The best of uro-oncology in 2017 Chairs: A. Breda, Barcelona (ES) M. Sedelaar, Nijmegen (NL)

11.00 - 11.15 Prostate cancer P. Ghadjar, Berlin (DE)

11.15 - 11.30 Renal cancer E. Linares Espinos, Madrid (ES)

11.30 - 11.45 Urothelial cancer A. Noon, Sheffield (GB)

11.45 - 12.00 Testis and penile cancer M. Salagierski, Zielona Gora (PL)

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

Sunday, 28 January

12.00 - 13.30 Renal cancer II: Locally advanced and metastatic Chairs: S. Brookman May, Munich (DE) O. Rodriguez Faba, Barcelona (ES)

12.00 - 12.15 The role of neoadjuvant and adjuvant therapy in kidney cancer A. Bamias, Athens (GR)

12.15 - 12.20 Discussion

12.20 - 12.35 Cytoreductive nephrectomy for metastatic RCC in the targeted therapy era V. Matveev, Moscow (RU)

12.35 - 12.40 Discussion

12.40 -12.55 The revival of immunotherapy in RCC and novel clinical trials A. Necchi, Milan (IT)

12.55 - 13.00 Discussion

13.00 - 13.30 Clinical case discussion Chair: A. Bamias, Athens (GR) Panelists: A. Bex, Amsterdam (NL) E. Linares Espinos, Madrid (ES) V. Matveev, Moscow (RU) A. Necchi, Milan (IT) O. Rodriguez Faba, Barcelona (ES)

13.30 - 13.35 Closing remarks M. Brausi, Modena (IT)

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

ESU/ESUI Hands-on Training in prostate MRI reading for urologists

Date 27 January 2018Time 14.30 - 18.00Room Hamburg, Passenger TerminalChair V. Kasivisvanathan, London (GB)Faculty J. Barentsz, Nijmegen (NL) V. Kasivisvanathan, London (GB) V. Panebianco, Rome (IT) F. Sanguedolce, Barcelona (ES)

14.30 - 14.40 The importance of prostate MRI to the urologist: Overview of the course V. Kasivisvanathan, London (GB)

14.40 - 15.10 Introduction to MRI sequences, scoring systems, PI-RADS J. Barentsz, Nijmegen (NL)

15.10 - 15.35 Interactive case discussion – reporting MRI using PI-RADS V. Panebianco, Rome (IT)

15.35 - 15.45 Treatment implications of an mpMRI-driven diagnostic pathway F. Sanguedolce, Barcelona (ES)

15.45 - 15.50 Introduction to the MIM software for MRI interpretation V. Kasivisvanathan, London (GB)

15.50 - 16.35 Assessment: Hands - on baseline assessment of MRI interpretation Supervised by Faculty

16.35 - 16.50 Review of assessment scans J. Barentsz, Nijmegen (NL)

16.50 - 17.35 Assessment: Hands - on baseline assessment of MRI interpretation Supervised by Faculty

17.35 - 17.50 Review of assessment scans V. Panebianco, Rome (IT)

17.50 - 18.00 Close

Registration fee: € 40 (excluding VAT)Limited places available – For further information please go to the registration desk.

ESOU18 15th Meeting of the EAU Section of Oncological Urology26-28 January 2018, Amsterdam, The Netherlands

www.esou18.org

ESU course on Kidney Cancer

Date 27 January 2018Time 14.30 – 17.30Room Matterhorn, Movenpick HotelChair J. Walz, Marseille (FR)

14.30 – 14.35 European School of Urology: A unique possibility for urological education J. Walz, Marseille (FR)

14.35 – 14.40 Introduction and aims J. Walz, Marseille (FR)

14.40 – 15.00 Diagnosis, biopsy and staging of kidney cancer J. Walz, Marseille (FR)

15.00 - 15.15 Management and treatment of kidney cancer

15.00 – 15.15 How to plan a surgical procedure and how to estimate surgical risk Speaker: B. Challacombe, London (GB)

15.15 - 16.04 Videos on how I do it:

15.15 – 15.25 Radical nephrectomy A. Bex, Amsterdam (NL)

15.25- 15.35 Partial nephrectomy B. Challacombe, London (GB)

15.35 – 15.45 Focal therapy J. Walz, Marseille (FR)

15.45 – 15.55 Active surveillance A. Minervini, Florence (IT)

15.55 – 16.05 Discussion

16.05 – 16.20 Break

16.20 – 16.50 Round table on how to avoid and manage complications Bleeding, Prolonged ischemia, Decreased renal function, Urinary and vascular fistulae Panel: A. Bex, Amsterdam (NL) B. Challacombe, London (GB) A. Minervini, Florence (IT) J. Walz, Marseille (FR)

16.50 – 17.05 Factors influencing functional and oncological outcome of kidney cancer treatment A. Minervini, Florence (IT)

17.05 – 17.25 Medical treatment of kidney cancer: “neoadjuvant” treatment of localized and advanced disease, Adjuvant treatment of kidney cancer, Treatment

of metastatic disease A. Bex, Amsterdam (NL)

17.25 - 17.30 Discussion and close

This course is available free to all delegates: No registration necessary.